Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States

Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution...

Descripción completa

Detalles Bibliográficos
Autores principales: Andam, Cheryl P., Worby, Colin J., Gierke, Ryan, McGee, Lesley, Pilishvili, Tamara, Hanage, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443431/
https://www.ncbi.nlm.nih.gov/pubmed/28518018
http://dx.doi.org/10.3201/eid2306.161331
_version_ 1783238561892401152
author Andam, Cheryl P.
Worby, Colin J.
Gierke, Ryan
McGee, Lesley
Pilishvili, Tamara
Hanage, William P.
author_facet Andam, Cheryl P.
Worby, Colin J.
Gierke, Ryan
McGee, Lesley
Pilishvili, Tamara
Hanage, William P.
author_sort Andam, Cheryl P.
collection PubMed
description Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.
format Online
Article
Text
id pubmed-5443431
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-54434312017-06-02 Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States Andam, Cheryl P. Worby, Colin J. Gierke, Ryan McGee, Lesley Pilishvili, Tamara Hanage, William P. Emerg Infect Dis Dispatch Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance. Centers for Disease Control and Prevention 2017-06 /pmc/articles/PMC5443431/ /pubmed/28518018 http://dx.doi.org/10.3201/eid2306.161331 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Andam, Cheryl P.
Worby, Colin J.
Gierke, Ryan
McGee, Lesley
Pilishvili, Tamara
Hanage, William P.
Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
title Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
title_full Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
title_fullStr Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
title_full_unstemmed Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
title_short Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
title_sort penicillin resistance of nonvaccine type pneumococcus before and after pcv13 introduction, united states
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443431/
https://www.ncbi.nlm.nih.gov/pubmed/28518018
http://dx.doi.org/10.3201/eid2306.161331
work_keys_str_mv AT andamcherylp penicillinresistanceofnonvaccinetypepneumococcusbeforeandafterpcv13introductionunitedstates
AT worbycolinj penicillinresistanceofnonvaccinetypepneumococcusbeforeandafterpcv13introductionunitedstates
AT gierkeryan penicillinresistanceofnonvaccinetypepneumococcusbeforeandafterpcv13introductionunitedstates
AT mcgeelesley penicillinresistanceofnonvaccinetypepneumococcusbeforeandafterpcv13introductionunitedstates
AT pilishvilitamara penicillinresistanceofnonvaccinetypepneumococcusbeforeandafterpcv13introductionunitedstates
AT hanagewilliamp penicillinresistanceofnonvaccinetypepneumococcusbeforeandafterpcv13introductionunitedstates

Ejemplares similares